Artemis Investment Management LLP Cuts Stake in Humana Inc. (NYSE:HUM)

Artemis Investment Management LLP reduced its stake in shares of Humana Inc. (NYSE:HUM) by 68.9% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 20,066 shares of the insurance provider’s stock after selling 44,507 shares during the period. Artemis Investment Management LLP’s holdings in Humana were worth $6,956,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in HUM. Paralel Advisors LLC lifted its stake in shares of Humana by 1.3% during the third quarter. Paralel Advisors LLC now owns 3,944 shares of the insurance provider’s stock worth $1,919,000 after buying an additional 49 shares during the period. LPL Financial LLC lifted its stake in shares of Humana by 1.8% during the third quarter. LPL Financial LLC now owns 28,265 shares of the insurance provider’s stock worth $13,752,000 after buying an additional 505 shares during the period. Westfield Capital Management Co. LP acquired a new stake in shares of Humana during the third quarter worth $235,000. Qube Research & Technologies Ltd lifted its stake in shares of Humana by 2.1% during the third quarter. Qube Research & Technologies Ltd now owns 157,802 shares of the insurance provider’s stock worth $76,774,000 after buying an additional 3,268 shares during the period. Finally, Tower Research Capital LLC TRC lifted its stake in shares of Humana by 86.6% during the third quarter. Tower Research Capital LLC TRC now owns 5,502 shares of the insurance provider’s stock worth $2,677,000 after buying an additional 2,553 shares during the period. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on HUM. Oppenheimer decreased their target price on shares of Humana from $415.00 to $370.00 and set an “outperform” rating for the company in a research report on Thursday, April 25th. UBS Group decreased their target price on shares of Humana from $334.00 to $326.00 and set a “neutral” rating for the company in a research report on Thursday, April 25th. TD Cowen decreased their target price on shares of Humana from $427.00 to $396.00 and set a “buy” rating for the company in a research report on Tuesday, April 2nd. Robert W. Baird began coverage on shares of Humana in a research report on Thursday, May 30th. They set a “neutral” rating and a $374.00 target price for the company. Finally, The Goldman Sachs Group decreased their target price on shares of Humana from $450.00 to $385.00 and set a “buy” rating for the company in a research report on Wednesday, April 3rd. Fourteen investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat.com, Humana currently has a consensus rating of “Hold” and an average price target of $409.55.

Humana Stock Up 2.9 %

HUM stock opened at $373.61 on Friday. The stock has a market capitalization of $45.02 billion, a P/E ratio of 23.26, a P/E/G ratio of 2.10 and a beta of 0.53. The firm has a 50-day simple moving average of $343.78 and a 200-day simple moving average of $351.97. The company has a quick ratio of 1.67, a current ratio of 1.67 and a debt-to-equity ratio of 0.77. Humana Inc. has a 52 week low of $298.61 and a 52 week high of $530.54.

Humana (NYSE:HUM) last released its earnings results on Wednesday, April 24th. The insurance provider reported $7.23 EPS for the quarter, topping analysts’ consensus estimates of $6.12 by $1.11. The business had revenue of $29.61 billion during the quarter, compared to analysts’ expectations of $28.52 billion. Humana had a net margin of 1.82% and a return on equity of 17.76%. The company’s quarterly revenue was up 10.7% on a year-over-year basis. During the same quarter in the previous year, the company earned $9.38 earnings per share. Equities analysts forecast that Humana Inc. will post 16.27 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be paid a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, June 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.95%. Humana’s dividend payout ratio is currently 22.04%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.